AstraZeneca stokes fears of London exit with New York listing

Sir Pascal Soriot, AstraZeneca’s CEO, has described the pharmaceuticals giant as a ‘very American company’ - Umit Bektas/Reuters AstraZeneca has announced plans to list shares on the New York Stock Exchange, stoking fears that Britain’s biggest drugmaker could quit London. In a shake-up announced on Monday, the FTSE pharmaceuticals giant said it would upgrade its US listing to ensure it is equally as important in New York as it is on the London Stock Exchange. Bosses said the move would make it easier f ...